211 filings
Page 9 of 11
8-K
bidv4b
9 Jun 17
Submission of Matters to a Vote of Security Holders
12:00am
EFFECT
qp3vj
9 Jun 17
Notice of effectiveness
12:00am
CORRESP
zblvk 5qdbsgnauz7wo
7 Jun 17
Correspondence with SEC
12:00am
8-K
6qj75gjwnqnhigy980
5 Jun 17
Regulation FD Disclosure
12:00am
S-3/A
e4iegn8 j4hcp
26 May 17
Shelf registration (amended)
12:00am
8-K
l5cc9phfbb0ml5liczz
4 May 17
Corvus Pharmaceuticals Reports First Quarter 2017 Financial Results and Provides Business Update
12:00am
8-K
b7de2
2 May 17
Entry into a Material Definitive Agreement
12:00am
DEFA14A
nf2t2kple bgf
24 Apr 17
Additional proxy soliciting materials
12:00am
DEF 14A
4ruuw69h65as19 016t
24 Apr 17
Definitive proxy
12:00am
UPLOAD
vmaim0imo6 9qa4ew2e
17 Apr 17
Letter from SEC
12:00am
PRE 14A
5i9 fha5u
5 Apr 17
Preliminary proxy
12:00am
8-K
s3izamxgl2g
4 Apr 17
Regulation FD Disclosure
12:00am
S-3
fonz5fx2
3 Apr 17
Shelf registration
12:00am
10-K/A
7uez4k 3op08
3 Apr 17
Annual report (amended)
12:00am
8-K
gjkx ett4n8a
10 Mar 17
Corvus Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Business Update
12:00am
S-8
ycti523 gjh7ehpof0jj
10 Mar 17
Registration of securities for employees
12:00am
10-K
kap1jrs i1wqhlst99
10 Mar 17
Annual report
12:00am
8-K
vg86w4w
14 Feb 17
Other Events
12:00am
8-K
frn1laszd05w omlt
10 Jan 17
Corvus Pharmaceuticals Announces Expansion of Renal Cell Carcinoma Cohort in Ongoing Phase 1/1b Clinical Study of Lead Checkpoint Inhibitor CPI-444
12:00am